2,2,2-Trifluoroethyl 5-((3-(4-cyclopropyl-1,2,3,4-tetrahydroquinoxaline-1-carbonyl)pyridin-4-yl)oxy)benzofuran-3-carboxylate

ID: ALA4784355

Chembl Id: CHEMBL4784355

PubChem CID: 162665892

Max Phase: Preclinical

Molecular Formula: C28H22F3N3O5

Molecular Weight: 537.49

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(OCC(F)(F)F)c1coc2ccc(Oc3ccncc3C(=O)N3CCN(C4CC4)c4ccccc43)cc12

Standard InChI:  InChI=1S/C28H22F3N3O5/c29-28(30,31)16-38-27(36)21-15-37-24-8-7-18(13-19(21)24)39-25-9-10-32-14-20(25)26(35)34-12-11-33(17-5-6-17)22-3-1-2-4-23(22)34/h1-4,7-10,13-15,17H,5-6,11-12,16H2

Standard InChI Key:  PZTWZDKTWIIJNG-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4784355

    ---

Associated Targets(Human)

GPBAR1 Tchem G-protein coupled bile acid receptor 1 (1723 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Gpbar1 G-protein coupled bile acid receptor 1 (577 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 537.49Molecular Weight (Monoisotopic): 537.1512AlogP: 5.97#Rotatable Bonds: 6
Polar Surface Area: 85.11Molecular Species: NEUTRALHBA: 7HBD:
#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): #RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 4.59CX LogP: 4.73CX LogD: 4.73
Aromatic Rings: 4Heavy Atoms: 39QED Weighted: 0.28Np Likeness Score: -0.90

References

1. Han F,Ning M,Cao H,Ye Y,Feng Y,Leng Y,Shen J.  (2020)  Design of G-protein-coupled bile acid receptor 1 (GPBAR1, TGR5) soft drugs with reduced gallbladder-filling effects.,  203  [PMID:32682201] [10.1016/j.ejmech.2020.112619]

Source